Pfizer Reaps Massive Profits From Vaccine

Pfizer’s first quarter financials are out, and its COVID-19 vaccine has proven to be an extremely profitable investment. It accounted for over a quarter of its total revenue.

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.